Automated high throughput human CYP isoform activity assay using SPE-LC/MS method: application in CYP inhibition evaluation
- 1 January 2000
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 30 (2) , 141-154
- https://doi.org/10.1080/004982500237749
Abstract
1. A high throughput screening (HTS) method for the evaluation of the seven major human hepatic CYP isoform activities was developed on a 96-well format, with automation. The method utilized pooled human liver microsomes and seven probe substrates, generic conditions for incubation, reaction termination and metabolite extraction with solid phase extraction (SPE) plates. Metabolites from the seven reactions were pooled and quantified using a generic liquid chromatography and tandem mass spectrometry (LCMS/MS) method. 2. The HTS method was validated based on Km values obtained, which were in agreement with literature data. 3. The isoform inhibition profiles of ketoconazole, quinidine, sulfaphenazole, tranylcypromine, alpha-naphthoflavone, and 4-methylpyrazole against CYPs 3A4, 2D6, 2C9, 2A6 (and 2C19), 1A2 and 2E1, respectively, were obtained by this HTS method. Graphically obtained IC50 values are in agreement with literature reported values. 4. The HTS method represents a significant efficiency and selectivity improvement over traditional methods, and can be used for CYP inhibition assay and can be extended for liver activity profiling.Keywords
This publication has 17 references indexed in Scilit:
- Fully automated analysis of activities catalysed by the major human liver cytochrome P450 (CYP) enzymes: assessment of human CYP inhibition potentialXenobiotica, 1999
- Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomesBritish Journal of Clinical Pharmacology, 1998
- Use of In Vitro and In Vivo Data to Estimate the Likelihood of Metabolic Pharmacokinetic InteractionsClinical Pharmacokinetics, 1997
- Use of cDNA-Expressed Human Cytochrome P450 Enzymes to Study Potential Drug-Drug InteractionsPublished by Elsevier ,1997
- Role of Cytochrome P450 Enzymes in Drug-Drug InteractionsPublished by Elsevier ,1997
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- Determination of P4501A2 activity in human liver microsomes using [3-14C-methyl]caffeineXenobiotica, 1995
- Catalytic properties of the human cytochrome P450 2E1 produced by cDNA expression in mammalian cellsArchives of Biochemistry and Biophysics, 1992
- Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1Chemical Research in Toxicology, 1990
- Inhibition of oxidative drug metabolism in microsomesPharmacology & Therapeutics, 1980